News
Innovative Medicines based on
ImmunoModulatory Biologics
-
Media Room
-
News
IMBiologics successfully closes series B financing round with 20B KRW
-
- Date
- 2023-07-26 14:49:56
-
- View
- 888
For more information, please visit : IMBiologics News (full article available in Korean)
- President(CEO) : Gyongsik Ha
- 260, Changnyong-daero, Yeongtong-gu, Suwon-si, Gyeonggi-do, Republic of Korea